NRDE NU RIDE INC. Insider Trading

Director Wartell purchases 6,548 shares of NRDE at $1.59; stock near 52-week lows; 90d cross-ticker track record 100% win rate

Wartell Michael J., a Director, acquired 6,548 shares at $1.59 on 2026-02-13, increasing his holdings by 3.0% to 227,081 shares total. The purchase occurred at a price 32.1% below the 52-week high of $2.49, during a period when the stock has gained 19.9% over 30 days and 18.2% over 90 days. His cross-ticker track record shows 100% win rate at the 90-day mark across 3 prior open-market purchases with an average 90d return of +16.1%, though his prior trades at NRDE itself are more mixed (2 of 2 measurable outcomes showed positive 90d returns, but one recent November buy has not yet had 90 days elapse). The company itself is in early-stage growth with annual revenue of $2,151,000.00 in the latest quarter and annual revenue growth of 1106.2%, though it remains unprofitable on a full-year basis.

Director-level fund ESOPUS CREEK VALUE acquires 40,000 shares ($58.0K) at $1.45 avg, now underwater; NRDE stock -46.2% from 52-week high despite 90d timing pattern of 50% win rate.

ESOPUS CREEK VALUE SERIES FUND LP - SERIES A executed 2 separate purchases totaling 40,000 shares for $58,024.91, expanding holdings from 723,000 to 763,000 shares (+5.5%). The blended average purchase price of $1.45 is now above the current price of $1.34, reflecting a -46.2% decline from the 52-week high of $2.49. At NRDE specifically, the insider's prior 4 measurable trades show a 50% win rate at the 90-day mark: 2 buys generated positive 90-day returns (+14.7%, +9.8%) while 2 buys fell sharply (-32.6%, -30.1%). The timing pattern is mixed rather than demonstrative of predictive skill. The company's latest quarterly revenue was $2,151,000.00 with net income of $955,000.00, but full-year results were negative, and the stock has declined 7.6% over 30 days and 37.7% over 90 days. The purchases represent continued accumulation into a deteriorating price environment with no public justification disclosed in the form itself.

NRDE Director Zyngier buys 32,328 shares at $1.34 avg; stock down -31.3% in 30d and -45.4% from 52-week high

Director Alexandre Zyngier executed 2 separate purchases totaling 32,328 shares for $43,296.24, with a blended average price of $1.34, increasing his holdings by 12.9% to 282,056 shares post-transaction. The stock has declined significantly: -31.3% over the past 30 days and -45.4% from its 52-week high of $2.49, trading now at $1.36. This activity occurs within a cluster pattern, as 2 other insiders also bought within the past 14 days. Zyngier's prior trades at NRDE showed favorable 90-day outcomes: his 3 prior measurable buys at this ticker delivered +16.8%, +21.0%, and +28.0% returns over 90 days. However, the company was unprofitable over its most recent full fiscal year, despite strong quarterly performance (Revenue $2,151,000.00, Net income $955,000.00), so fundamental context remains mixed.

Director buy: 8,000 shares of NRDE at $1.45; stock down 49.0% from 52-week high; cluster pattern with 2 other insiders in 14 days

ESOPUS CREEK VALUE SERIES FUND LP - SERIES A (Director) purchased 8,000 shares at $1.45 on 2025-11-19 in open market, increasing holdings to 723,000 shares. The transaction occurs while the stock trades at $1.27, down 49.0% from its 52-week high of $2.49 and down 36.5% over 30 days. This purchase is part of a cluster pattern with 2 other insiders buying within the past 14 days. Examining the director's prior NRDE trades, of 5 previous buys, only 2 were followed by positive 90-day returns (both in April 2025 with +14.7% and +9.8%), while 3 earlier purchases in March 2024 each showed 90d declines of -24.4% to -32.6%. The cross-ticker track record shows an average 90d return of -12.5% with a 40% win rate. The company's fundamentals are mixed: latest quarter revenue of $2.2M with net income of $955.0K, but full-year net income was negative despite +1106.2% annual revenue growth. The combination of severe near-term price deterioration, mixed timing history at this specific ticker, and negative full-year profitability presents a routine insider purchase signal without strong conviction indicators.

Director Wartell purchases 100,000 shares across 3 transactions for $139,500.00 as stock down 49.0% from 52-week high; 2 other insiders also bought in past 14 days

Michael J. Wartell, Director, executed 3 separate purchases totaling 100,000 shares for $139,500.00 between November 19–21, 2025, at prices ranging from $1.37 to $1.42, while the stock trades at $1.27 (49.0% below its 52-week high of $2.49). His holdings increased 83.0% from 120,533 to 220,533 shares. The company posted exceptional revenue growth (+1106.2% annually) and generated positive quarterly net income of $955,000.00, yet reported negative full-year earnings, signaling structural profitability challenges despite near-term operational strength. A cluster pattern emerges: 2 other insiders also acquired shares within the past 14 days, suggesting coordinated confidence among multiple board/management participants amid the stock's recent decline. The timing occurs after the 30-day drawdown of 36.5%, placing the entry near depressed levels relative to recent trading history.

Director Zyngier buys 57,252 shares at $1.35–$1.36 across 2 transactions for $77,761.16; stock down 42.6% from 52-week high; cluster buy pattern detected.

ZYNGIER ALEXANDRE, a Director, executed 2 separate purchases totaling 57,252 shares for $77,761.16 at a blended average price of $1.36 on November 18–19, 2025, increasing his holdings by 29.7% to 249,728 shares. The stock is currently trading at $1.43, down 42.6% from its 52-week high of $2.49, and has declined 28.5% over the past 30 days. His prior trades at NRDE show mixed timing outcomes: 3 of 5 prior buys were well-timed at the 90-day horizon, with returns ranging from −15.9% to +28.0%, though the most recent prior buys (May 2025) showed positive 90-day returns of +16.8% to +21.0%. A cluster buy pattern is present, with 2 other insiders also purchasing within the past 14 days. The company reported $2.2M quarterly revenue and $955.0K net income, but was unprofitable on a full-year basis; annual revenue growth was +1106.2%, though absolute scale remains modest at a $23.0M market cap.

Director ZYNGIER ALEXANDRE bought 9,972 shares for $12,456.47 (blended $1.25) at NRDE; holds 192,474 shares post-transaction (+5.5%).

ZYNGIER ALEXANDRE, a director at NU RIDE INC., executed 3 separate purchases totaling 9,972 shares for $12,456.47 between April 29 and May 1, 2025, at prices ranging from $1.24 to $1.25. His prior buys at NRDE showed negative 90-day returns (-15.9% and -13.8%), and his cross-ticker track record across 2 prior buys yielded an average 90-day return of -13.8% with a 0.00% win rate. The stock currently trades at $1.36, up 7.9% over 90 days but still -32.0% from its 52-week high of $2.00. Company fundamentals show annualized revenue growth of +1106.2% and recent quarterly net income of $338,000.00, though the company was unprofitable over its most recent full fiscal year. The purchase occurs in a stock that has historically underperformed in the 90-day periods following his prior acquisitions at this ticker.

Director fund buys 15,000 shares at $1.32 blended average; stock now at $1.25, -6.0% in 30 days; prior NRDE buys all negative at 90-day mark.

ESOPUS CREEK VALUE SERIES FUND LP - SERIES A (Director) executed 2 purchases totaling 15,000 shares for $19,836.75 at a blended average price of $1.32 on 2025-04-24 and 2025-04-25, expanding holdings from 700,000 to 715,000 shares. The current price is $1.25, down 6.0% over the prior 30 days and -37.5% from the 52-week high of $2.00. The director's prior trades at NRDE show a consistent pattern of poorly timed entries: 3 prior buys on this ticker (2024-03-14, 2024-03-15, 2024-03-18) all produced negative 90-day returns (-23.5%, -25.3%, -19.5% respectively), with 0 of 3 achieved positive outcomes at the 90-day mark. The company's fundamentals remain challenged: annual revenue growth of +1106.2% masks a modest latest-quarter revenue of $2,151,000.00, net income of $338,000.00 in the latest quarter, yet a full-year net income that was negative, and a market cap of only $20,120,370.00. This purchase aligns with a historical pattern of ill-timed entries by this insider at this specific ticker, warranting investor attention to execution timing risk.

Director ZYNGIER ALEXANDRE bought 60,900 shares in 2 transactions ($89,746.08) at $1.45–$1.51, raising stake 50.1% to 182,502 shares

ZYNGIER ALEXANDRE, a director at NU RIDE INC., executed 2 separate purchases totaling 60,900 shares for $89,746.08, with transaction prices of $1.45 on 2024-11-22 and $1.51 on 2024-11-26 — both near the current price of $1.46. The blended average purchase price of $1.47 places this buying near current valuation levels, not at a significant discount. This transaction increases his stake by 50.1%, from 121,602 to 182,502 shares, representing a substantial increase in his direct ownership. The company exhibited exceptional annual revenue growth of +1106.2% in its most recent fiscal year but was unprofitable over the full year, creating a tension between growth trajectory and current profitability. The stock is currently down 36.8% from its 52-week high of $2.31, presenting a context of recent underperformance even as the insider chose to accumulate at levels well below peak pricing.